EDGAR Filing Documents for 0001801170-23-000115

Form 8-K - Current report:

SEC Accession No. 0001801170-23-000115

Filing Date

2023-12-01

Accepted

2023-12-01 08:16:22

Documents

Period of Report

2023-11-30

Items

Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	clov-20231130.htm iXBRL	8-K	34896
2	EX-99.1	december12023pressrelease.htm	EX-99.1	9695
	Complete submission text file	0001801170-23-000115.txt		179877

Data Files

Seq	Description	Document	Type	Size
3	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	clov-20231130.xsd	EX-101.SCH	1904
4	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	clov-20231130_lab.xml	EX-101.LAB	24851
5	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	clov-20231130_pre.xml	EX-101.PRE	13048
7	EXTRACTED XBRL INSTANCE DOCUMENT	clov-20231130_htm.xml	XML	2840

Mailing Address 3401 MALLORY LANE, SUITE 210 FRANKLIN TN 37067

Business Address 3401 MALLORY LANE, SUITE 210 FRANKLIN TN 37067 (201) 432-2133

CLOVER HEALTH INVESTMENTS, CORP. /DE (Filer) CIK: 0001801170 (see all company filings)